IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED Financials
- Company number
- 02935871Copy
Copy - Registered office
- 4e The Lanterns, 16 Melbourn Street, Royston SG8 7BX
- Incorporated
- 06/06/1994
Company snapshot
- Status
- Active
- Employees
- 5 (2024)
- Latest financial data
- 2024
- Accounts type
- Unaudited abridged
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2024.
Net Assets
-12.85%vs 20232023: £435.18K
Total Assets
-14.21%vs 20232023: £478.33K
Cash in Bank
-19.71%vs 20232023: £151.21K
Total Liabilities
-26.96%vs 20232023: £39.94K
Employees
-1vs 20232023: 6
In 2024, IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED reported net assets of £379.24K. The same filing shows total assets of £410.35K, cash in bank of £121.40K and total liabilities of £29.17K. Reported headcount was 5 in 2024. Total Assets fell from £478.33K in 2023 to £410.35K in 2024 (-14.21%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-12.85%from £435.18K in 2023Year-on-year change
Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.
3-year financial trend (2022–2024)
How the figures IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.
Net Assets
-36.7%vs 2022-20.5% a year compound (CAGR)
Cash in Bank
+72.4%vs 2022+31.3% a year compound (CAGR)
Total Assets
-38.7%vs 2022-21.7% a year compound (CAGR)
Total Liabilities
-56.3%vs 2022-33.9% a year compound (CAGR)
Employees
-16.7%vs 2022-1Biggest increase
Cash in Bank+72.4%
£70.43K in 2022 to £121.40K in 2024
Biggest decrease
Total Liabilities-56.3%
£66.81K in 2022 to £29.17K in 2024
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED's filings pull in both directions between 2022 and 2024. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 92.42%2024
- Liabilities to total assets
- 7.11%2024
- Cash to liabilities
- 416.14%2024
- Cash to total assets
- 29.58%2024
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net Assets£ | 641.27K | 599.49K | 435.18K | 379.24K |
| Total Assets£ | 708.64K | 668.93K | 478.33K | 410.35K |
| Cash in Bank£ | 51.31K | 70.43K | 151.21K | 121.40K |
| Total Liabilities£ | 64.38K | 66.81K | 39.94K | 29.17K |
| Employees | 6 | 6 | 6 | 5 |
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED filed financial statements?
Yes. Okredo holds filed figures for IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED covering 2021–2024, across 5 reported indicators. The most recent reported year is 2024.
What net assets did IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED report in 2024?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED reported net assets of £379.24K for 2024. That compares with £435.18K in 2023, a change of -12.85%.
What total assets did IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED report in 2024?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED reported total assets of £410.35K for 2024. That compares with £478.33K in 2023, a change of -14.21%.
What cash in bank did IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED report in 2024?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED reported cash in bank of £121.40K for 2024. That compares with £151.21K in 2023, a change of -19.71%.
How many people does IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED employ?
IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED reported 5 employees in 2024, compared with 6 in 2023.
How have IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED financials changed over the last 3 years?
Between 2022 and 2024, IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED's net assets fell by 36.7%, cash in bank rose by 72.4%, total assets fell by 38.7% and total liabilities fell by 56.3%. Net assets contracted at 20.5% a year across the two years to 2024, from £599.49K to £379.24K. Reported headcount went from 6 in 2022 to 5 in 2024 (-1).
Which years of IDEA INNOVATIVE DRUG EUROPEAN ASSOCIATES LIMITED financial data are available?
Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.